vecuronium bromide has been researched along with Benign Supratentorial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karwacki, Z; Niewiadomski, S; Rzaska, M | 1 |
| Caldwell, JE; McCarthy, G; Sharma, ML; Szenohradszky, J; Wright, PM | 1 |
1 trial(s) available for vecuronium bromide and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
The use of sugammadex for the reversal of vecuronium-induced neuromuscular block following intracranial surgery.
Topics: Adult; Aged; Anesthesia Recovery Period; Anesthesia, Intravenous; Body Temperature; Craniotomy; Female; gamma-Cyclodextrins; Hemodynamics; Humans; Male; Middle Aged; Neural Conduction; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Pain, Postoperative; Sugammadex; Supratentorial Neoplasms; Vecuronium Bromide | 2015 |
1 other study(ies) available for vecuronium bromide and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium.
Topics: Adult; Anticonvulsants; Biotransformation; Craniotomy; Drug Interactions; Female; Humans; Male; Middle Aged; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Phenytoin; Supratentorial Neoplasms; Vecuronium Bromide | 2004 |